Whole Exome Sequencing Study Suggests an Impact of FANCA, CDH1 and VEGFA Genes on Diffuse Gastric Cancer Development

Genes (Basel). 2023 Jan 21;14(2):280. doi: 10.3390/genes14020280.

Abstract

Gastric cancer (GC) is one of the most common cancer types in the world with a high mortality rate. Hereditary predisposition for GC is not fully elucidated so far. The aim of this study was identification of possible new candidate genes, associated with the increased risk of gastric cancer development. Whole exome sequencing (WES) was performed on 18 DNA samples from adenocarcinoma specimens and non-tumor-bearing healthy stomach tissue from the same patient. Three pathogenic variants were identified: c.1320+1G>A in the CDH1 gene and c.27_28insCCCAGCCCCAGCTACCA (p.Ala9fs) of the VEGFA gene were found only in the tumor tissue, whereas c.G1874C (p.Cys625Ser) in the FANCA gene was found in both the tumor and normal tissue. These changes were found only in patients with diffuse gastric cancer and were absent in the DNA of healthy donors.

Keywords: gastric cancer; germline mutations; pathogenic variants; somatic mutations; whole exome sequencing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD
  • Cadherins / genetics
  • Exome Sequencing
  • Fanconi Anemia Complementation Group A Protein / genetics
  • Fanconi Anemia*
  • Genetic Predisposition to Disease
  • Germ-Line Mutation
  • Humans
  • Stomach Neoplasms* / genetics
  • Vascular Endothelial Growth Factor A / genetics

Substances

  • FANCA protein, human
  • Fanconi Anemia Complementation Group A Protein
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • CDH1 protein, human
  • Antigens, CD
  • Cadherins

Grants and funding

Whole exome sequencing, bioinformatic analysis have been supported by State Assignment of the Ministry of Science and Higher Education of Russian Federation No. 075-03-2021-193/5.